|

Ado-trastuzumab (T) emtansine (T-DM1) Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Also known as: Kadcyla

Pipeline

Phase 2: 1

Top Sponsors

  • Dana-Farber Cancer Institute1

Indications

  • HER2 Gene Mutation1
  • Salivary Gland Cancer1
  • Cancer1

Atlanta, Georgia1 trial

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

Winship Cancer Institute, Emory University

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.